Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center

Hrkač, Stela; Tečer, Josip; Lazibat, Karla; Ristov, Ana; Šalamon, Lea; Morović-Vergles, Jadranka; Mitrović, Joško

doi:10.33004/reumatizam-supp-72-1-38

Reumatizam, Vol. 72 No. Supp 1, 2025.

Sažetak sa skupa

https://doi.org/10.33004/reumatizam-supp-72-1-38

Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center

Stela Hrkač *
Josip Tečer
Karla Lazibat
Ana Ristov
Lea Šalamon
Jadranka Morović-Vergles
Joško Mitrović

* Dopisni autor.

Puni tekst: hrvatski pdf 652 Kb

str. 48-48

preuzimanja: 153

citiraj

APA 6th Edition

Hrkač, S., Tečer, J., Lazibat, K., Ristov, A., Šalamon, L., Morović-Vergles, J. i Mitrović, J. (2025). Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center. Reumatizam, 72 (Supp 1), 48-48. https://doi.org/10.33004/reumatizam-supp-72-1-38

MLA 8th Edition

Hrkač, Stela, et al. "Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center." Reumatizam, vol. 72, br. Supp 1, 2025, str. 48-48. https://doi.org/10.33004/reumatizam-supp-72-1-38. Citirano 14.08.2026.

Chicago 17th Edition

Hrkač, Stela, Josip Tečer, Karla Lazibat, Ana Ristov, Lea Šalamon, Jadranka Morović-Vergles i Joško Mitrović. "Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center." Reumatizam 72, br. Supp 1 (2025): 48-48. https://doi.org/10.33004/reumatizam-supp-72-1-38

Harvard

Hrkač, S., et al. (2025). 'Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center', Reumatizam, 72(Supp 1), str. 48-48. https://doi.org/10.33004/reumatizam-supp-72-1-38

Vancouver

Hrkač S, Tečer J, Lazibat K, Ristov A, Šalamon L, Morović-Vergles J i sur. Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center. Reumatizam [Internet]. 2025 [pristupljeno 14.08.2026.];72(Supp 1):48-48. https://doi.org/10.33004/reumatizam-supp-72-1-38

IEEE

S. Hrkač, et al., "Major adverse cardiovascular events in patients treated with Janus kinase inhibitors – data from our center", Reumatizam, vol.72, br. Supp 1, str. 48-48, 2025. [Online]. https://doi.org/10.33004/reumatizam-supp-72-1-38

Sažetak

Ključne riječi

Hrčak ID:

339568

URI

https://hrcak.srce.hr/339568

Datum izdavanja:

5.11.2025.

Podaci na drugim jezicima: hrvatski

Posjeta: 684 *

Prijava i registracija

Reumatizam, Vol. 72 No. Supp 1, 2025.

Sažetak

Ključne riječi

Hrčak ID:

URI

Datum izdavanja: